NIH invested another $48 million to support the inclusion of genomic data in electronic health records

Source: Biovalley, September 9, 2015, NIH recently announced that it will invest a total of US $48 million to collect and integrate genomic information and record it into the electronic health record system According to the plan, NIH will fund at least ten research institutions to take charge of one aspect of the plan The main purpose of NIH's plan is to improve the electronic health case system and medical insurance system and serve the precision medical plan Among them, brightam and women's Hospital and Baylor College of medicine will share the largest cake The two research institutions will serve as the sequencing and genotyping center of NIH's plan, sharing a total of US $16.9 million in R & D funds in the next four years At present, the research funds have been in place, and the specific allocation of funds will depend on the work progress of each research institution Dr rongling li of NIH said in the statement that the new funding plan aims to use the latest sequencing technology to find gene types that can help clinical treatment and drug development of diseases NIH plans to study a total of 100 disease-related genes In addition to the two research units mentioned above, NIH also selected ten research teams as partners, among which Columbia University, Mayo Medical College, Geisinger health system and other important research institutions are listed Among them, Mayo Medical eye will be responsible for the genetic analysis of hypercholesterolemia and colon cancer, while Geisinger will be mainly responsible for the collection of DNA information and electronic health record data to analyze the pathogenesis of related diseases Since US President Barack Obama proposed the concept of precision medical plan FDA and NIH have issued a series of plans in response to this huge research plan Previously, FDA has established a platform called "precision FDA" to store and share gene information provided by researchers, new generation sequencing technology developers, etc (related reading: response to "precision medicine" FDA to establish a gene big data sharing platform!) The creation of this platform is also expected to help FDA establish a unified standard to evaluate DNA sequencing based detection methods in the future.